| Financial Year |
March 31 2023 |
| Monetary Funds |
255,770,187.76 |
| Held-for-trading Financial Assets |
90,335,330.29 |
| Notes Receivable |
18,482,596.85 |
| Accounts Receivable |
502,534,078.10 |
| Advances to Suppliers |
8,268,481.45 |
| Other Receivables |
18,568,654.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
145,471,580.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,044,055.94 |
| Total Current Assets |
1,055,242,627.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
80,489,772.02 |
| Fixed Assetes |
421,066,032.33 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,717,625.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
844,308.64 |
| Deferred Income Tax Assets |
82,415,807.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
702,070,298.32 |
| Total Assets |
1,757,312,925.65 |
| Short-Term Loans |
188,108,163.16 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,928,784.54 |
| Accounts Payable |
292,930,413.57 |
| Accounts Received In Advance |
166,904.63 |
| Employee Compensation Payable |
3,150,929.19 |
| Taxes Payable |
5,347,290.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,109,831.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
96,378,206.30 |
| Other Current Liabilities |
1,153,756.23 |
| Sub-Total of Current Liabilities |
654,814,982.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,283,910.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
75,104,732.71 |
| Total Liabilities |
729,919,715.44 |
| Paid-In Capital(Or Share Stock) |
160,589,840.00 |
| Capital Surplus |
723,510,882.56 |
| Surplus Reserve |
21,816,879.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
49,380,063.40 |
| Minority Stockholder's Interest |
72,204,312.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
955,188,898.00 |
| Owner's Equity（Stockholder's Equity） |
1,027,393,210.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,757,312,925.65 |
